- WHO coordinates with DHL to deliver healthcare supplies to Pacific Islands
- Israel discovers antibody combo to fight COVID-19
- Takeda makes Nihon Pharma wholly owned subsidiary
- INVO Bioscience and idsMED Group sign distribution agreement for Malaysia
- Korea inks MoU with Ecuador for global health R&D
- Australia to undertake clinical studies of needle-free vaccine patch
- Omron leads $65M investment round for AliveCor
- Duke-NUS expert joins Lancet COVID-19 commission taskforce
- Sputnik V vaccine single dose to be less than $10 at international markets
- Korea's OliPass advisory board to evaluate osteoarthritis pain killer drug development
- Japan's Fujitsu drives digital transformation in hospitals and clinics
- Taiwan initiates new measures for management of medical masks
- I-Mab reports efficacy of Anti-CD47 monoclonal Ab on relapsed/refractory malignancy
- Korea pushes vaccine R&D for global health
-
Premium Article | 30 September 2020 | Influencers
"We Are Planning To Deliver Products With Better Efficiency For APAC customers "
Cytiva, formerly GE Healthcare Life Sciences, has recently announced an investment of $500 million for expansi...Read more
World | 20 March 2020 | Influencers
Eppendorf is investing disproportionately in expansion of its global locations, particularly in Asia
Congratulations on your new role. What are the main agendas behind the recently announced dual leadership at E...Read more
-
CMC & Manufacturing | 06 November 2020 | News
Thermo Fisher to establish new pharma services facility in China
Thermo Fisher Scientific Inc. has signed a joint venture agreement to establish a new pharma services facility...Read more
-
Korea | 26 November 2020 | News
Korea inks MoU with Ecuador for global health R&D
The International Vaccine Institute (IVI) and Ministry of Foreign Affairs and Human Mobility of Ecuador exchan...Read more
-
Japan | 25 November 2020 | News
Japan's Fujitsu drives digital transformation in hospitals and clinics
Fujitsu on 25 Nov 2020 announced the commercial debut of its "FUJITSU Healthcare Solution Online Healthcare So...Read more
-
China | 25 November 2020 | Company results
I-Mab reports efficacy of Anti-CD47 monoclonal Ab on relapsed/refractory malignancy
I-Mab, a global clinical-stage biopharmaceutical company based in China and the US and committed to the discov...Read more
REFRAME DIABETIC RETINOPATHY
Diabetic retinopathy (DR), the most common complication of diabetes mellitus, is the leading cause of new cases of blindness in middle-aged and elderly in the world. It has been estimated that 51 per cent of all those with blindness due to DR globally and 56 per cent of those with visual impairment due to DR come from the Asia-Pacific (APAC) region. This is mainly due to the fact that management and awareness of DR in the APAC region is limited and sub-optimal. This year, as we celebrate Word Diabetes Day on November 14, we must address the urgent need to improve the screening and diagnosis of DR within the APAC countries
